Literature DB >> 30317990

Preparation of Cationic Lipid-coated Ultrasound Contrast Agents and Noninvasive Gene Transfection Via Ultrasound-targeted Microbubble Destruction.

Feng Yang1, Yue Li1, Chun Liufu1, Yi Wang1, ZhiYi Chen1.   

Abstract

PURPOSE: Ultrasound contrast agents involving a therapeutic drug applied during enhanced imaging can be used for targeted therapy. The preparation of contrast agents is a precondition and basis for the use of multifunctional contrast agents in molecular imaging.
METHODS: This study uses thin-film hydration-mechanical vibration to carry out the preliminary preparation of a cationic contrast agent (CCA); characterizes the particle diameter, potential, distribution, and concentration of the agents; and optimizes the factors affecting the preparation of the agents.
RESULTS: This study found that thin-film hydration-mechanical vibration methods offer a better preparation effectiveness and achieve smaller particle diameters and more even distributions, as well as give better imaging performance. Different concentrations of CCA and plasmid and different gene transfection methods can produce different degrees of sonoporation to achieve optimal transfection efficiency. Ultrasound parameters have a great influence on transfection efficiency and plasmid integrity. A previous study confirmed that the ultrasound parameters of 1 MHz, 1 W/cm2, a duty cycle controller (DC) of 20%, and irradiation for 1 min can well deliver genes to tumor cells, with little impact on cell survival.
CONCLUSION: Our findings indicate that ultrasound-targeted microbubble destruction (UTMD)-mediated CCA destruction facilitates gene transfection and may represent an effective gene delivery method for cervical cancer therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cationic Contrast Agent (CCA); Ultrasound contrast agent; Ultrasoundtargetedzzm321990Microbubble Destruction (UTMD); cationic; gene transfection; thin-film hydration method.

Mesh:

Substances:

Year:  2018        PMID: 30317990     DOI: 10.2174/1381612824666181011120031

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Ultrasound microbubble-mediated RNA interference targeting WNT1 inducible signaling pathway protein 1(WISP1) suppresses the proliferation and metastasis of breast cancer cells.

Authors:  Faying Fang; Weizhi Xu; Jian Zhang; Jin Gu; Gaoyi Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  CMBs carrying PTX and CRISPR/Cas9 targeting C‑erbB‑2 plasmids interfere with endometrial cancer cells.

Authors:  Siyuan Peng; Junhong Cai; Shan Bao
Journal:  Mol Med Rep       Date:  2021-09-30       Impact factor: 2.952

3.  UTMD promoted local delivery of miR-34a-mimic for ovarian cancer therapy.

Authors:  Yue Li; Meng Du; Jinghui Fang; Jia Zhou; Zhiyi Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.